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Coxiella burnetii is a Gram-negative, obligate intracellular bacterial pathogen that resides within the harsh,
acidic confines of a lysosome-like compartment of the host cell that is termed a parasitophorous vacuole. In
this study, we characterized a thiol-specific peroxidase of C. burnetii that belongs to the atypical 2-cysteine
subfamily of peroxiredoxins, commonly referred to as bacterioferritin comigratory proteins (BCPs). Coxiella
BCP was initially identified as a potential DNA-binding protein by two-dimensional Southwestern (SW) blots
of the pathogen’s proteome, probed with biotinylated C. burnetii genomic DNA. Confirmation of the identity of
the DNA-binding protein as BCP (CBU_0963) was established by matrix-assisted laser desorption ionization–
tandem time of flight mass spectrometry (MALDI-TOF/TOF MS). Recombinant Coxiella BCP (rBCP) was
generated, and its DNA binding was demonstrated by two independent methods, including SW blotting and
electrophoretic mobility shift assays (EMSAs). rBCP also demonstrated peroxidase activity in vitro that
required thioredoxin-thioredoxin reductase (Trx-TrxR). Both the DNA-binding and peroxidase activities of
rBCP were lost upon heat denaturation (100°C, 10 min). Functional expression of Coxiella bcp was demonstrated by trans-complementation of an Escherichia coli bcp mutant, as evidenced by the strain’s ability to grow
in an oxidative-stress growth medium containing tert-butyl hydroperoxide to levels that were indistinguishable
from, or significantly greater than, those observed with its wild-type parental strain and significantly greater
than bcp mutant levels (P < 0.05). rBCP was also found to protect supercoiled plasmid DNA from oxidative
damage (i.e., nicking) in vitro. Maximal expression of the bcp gene coincided with the pathogen’s early (day 2
to 3) exponential-growth phase in an experiment involving synchronized infection of an epithelial (Vero) host
cell line. Taken as a whole, the results show that Coxiella BCP binds DNA and likely serves to detoxify
endogenous hydroperoxide byproducts of Coxiella’s metabolism during intracellular replication.
shifted Cu/Zn-SOD gene (e.g., Dugway) or a markedly truncated catalase gene (Nine Mile or G) (18), suggesting that
these strains, likely undergoing reductive evolution in the intracellular niche, must resort to alternative effectors for protection against ROS.
For this report, we characterized the Coxiella BCP
(CBU_0963), a representative of a 2-cysteine (2-Cys) Prx
subfamily that is widely employed by pathogenic bacteria to
deal with potentially toxic H2O2 and organic hydroperoxides. We demonstrate that the bcp gene of Coxiella bacteria
is maximally expressed during early exponential-phase
growth and that BCP is a DNA-binding protein that exhibits
peroxidase activity and can protect supercoiled DNA from
oxidative damage in vitro.

Coxiella burnetii is a Gram-negative bacterium that causes Q
fever in humans. Growth of the pathogen is restricted to an
intracellular lysosome-like compartment, termed a parasitophorous vacuole (PV). The pH (⬃4.5) of the PV is ideal for C.
burnetii’s acidophilic lifestyle (11, 12); however, the effect of
concomitant oxidative stress on the bacterium and the defense
mechanisms used to counter it have not been well characterized.
Bacteria deal with oxidative stress by employing antioxidants
such as glutathione, vitamins A, C, and E, and carotenoids, and
they counter reactive oxygen species (ROS) by using a variety
of enzymatic effectors, including superoxide dismutase (SOD),
catalase, and peroxidase. Previous work suggests that catalase
and SOD are potential persistence factors for Coxiella bacteria
residing in the intracellular niche (1, 14). In addition, a secreted acid phosphatase possibly reduces the respiratory burst
of the host cell by inhibiting NADPH oxidase (4, 23). in silico
analysis of the C. burnetii RSA 493 genome (22) revealed
predicted Mn- and Cu/Zn-SODs, catalase, and four peroxiredoxins (Prxs), which are antioxidant enzymes (EC 1.11.1.15)
that are thiol-containing reductants used to detoxify hydroperoxides. Interestingly, certain C. burnetii strains possess a frame-

MATERIALS AND METHODS
Bacterial strains, cell lines, and growth conditions. Nine Mile phase II C.
burnetii (strain RSA 439, clone 4) was propagated in African green monkey
kidney (Vero) epithelial cells (CCL-81; American type Culture Collection
[ATCC], Manassas, VA), as previously described (21). C. burnetii small cell
variants (SCVs) were prepared and purified as described before (21). The resulting SCVs were used to inoculate Vero cell monolayers to produce synchronized infections (8).
Escherichia coli strains were grown overnight at 37°C in Luria-Bertani (LB)
medium. Supplements of chloramphenicol (20 g/ml), kanamycin (50 g/ml), or
ampicillin (LBamp) (100 g/ml) were added to the medium, as required. Two E.
coli strains (DH5␣ and JM109) were used for routine cloning and plasmid
production, and a third strain (M15 [pREP4]; Qiagen, Valencia, CA) was used
for production of recombinant BCP (rBCP) expressed from cloned Coxiella bcp.
An E. coli bcp mutant (JS2465-1) and an otherwise isogenic parental strain,
BW25113, were obtained from the E. coli Genetic Stock Center (CGCS). An
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TABLE 1. Bacterial strains, cell line, plasmids, and PCR primers
used in the study
Designation
Strains
C. burnetii
RSA 439
E. coli
DH5␣
JM109
M15 (pREP4)
JS2465-1
BW25113
LH001
LH100
LH200
LH300
LH400
LH500
LH600
LH700
Cell line
Vero
Plasmids
pUC19
pCP20
pQE30, 31
pREP4
pQBCP
pQCOM1
pQHBPA
PCR primers
BCP_For
BCP_Rev
BCP2_For
BCP2_Rev
a

Relevant characteristic(s)

Source or
reference

Nine Mile Phase II, clone 4

R. A.
Heinzen

Host strain for plasmid production
Host strain for cloning
Host strain for His6 fusion proteins
bcp-728⌬::kan
Parent strain to JS2465-1
In-frame bcp mutant derived from
JS2465-1
LH001 containing pQBCP
LH001 containing pQE30
BW25113 containing pQE30
M15 (pREP4) containing pQE30
M15 (pREP4) containing pQBCP
M15 (pREP4) containing pQCOM1
M15 (pREP4) containing pQHBPA

Gibco-BRL
Promega
Qiagen
CGSC (3)
CGSC (3)
This study

Green monkey epithelial line

ATCC
CCL-81

High-copy-number cloning vector
flp⫹, Repts, Apr, Cmra
Expression vectors for His6 fusion
proteins
lacI⫹ in trans repressor plasmid
pQE30 with cloned Coxiella bcp
and sdr
pQE30 with cloned Coxiella com1
pQE31 with cloned Bartonella
quintana hbpA

30
5
Qiagen

GCGCATGCTCCATTGAAGTCG
GCCAGAAGG
TCGCTGCAGGCTTGGTTAGCT
GAACATAC
TGAATGATTGATGTGCTTT
AACG
CGGATGAAGGCGAAATGC

This study

This
This
This
This
This
This
This

study
study
study
study
study
study
study

Qiagen
This study
This study
This study

This study
This study
This study

Ap, ampicillin; Cm, chloramphenicol; ts, temperature sensitive; s, susceptible.

in-frame bcp deletion mutant was generated by transforming (6) JS2465-1 with
pCP20 to utilize the encoded Flp recombinase for excision of bcp-728⌬::kan, as
previously described (5). The resulting strain, LH001, was transformed with the
plasmids pQBCP and pQE30 (Qiagen) to generate strains LH100 and LH200,
respectively. BW25113 was transformed with pQE30 (Qiagen) to create strain
LH300. A summary of data for these strains, plasmids, and the cell line is
provided in Table 1.
2D SDS-PAGE and Southwestern (SW) blots. Proteins from a total cell lysate
were prepared by adding 500 l of purified SCVs (⬃8 ⫻ 1010 genomes) to an
equal volume of lysis buffer (50 mM Tris-HCl [pH 7.5], 50 mM NaCl, 50 mM
MgCl2, 5 mM dithiothreitol [DTT], and a “Complete Mini” protease inhibitor
cocktail tablet [Roche Diagnostics, Indianapolis, IN]). Approximately 500 l of
0.1-mm-diameter glass beads was added to the mixture, cells were vortexed
overnight at 4°C using a Disruptor Genie (Scientific Industries, Bohemia, NY),
and the resulting lysate was centrifuged (10,000 ⫻ g for 10 min, 4°C) to remove
cellular debris. The supernatant was collected and the protein concentration
determined with a bicinchoninic acid (BCA) protein assay kit per the manufacturer’s instructions (Thermo Scientific, Rockford, IL). Two-dimensional sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (2D SDS-PAGE) was done
using 70 g of protein and the general methods of O’Farrell (20). For the first
dimension, a Protean isoelectric focusing (IEF) cell was used with nonlinear
IEF strips (pI, 3 to 10) as instructed by the manufacturer (Bio-Rad, Hercules,

CA). The resulting IEF strips were resolved in the second dimension using
12.5% (wt/vol) acrylamide SDS slab gels. 2D gels were stained with SilverQuest as instructed by the manufacturer (Invitrogen, Carlsbad, CA) or immediately blotted.
For SW blotting, 2D gels were incubated for 3 h in renaturing buffer (10 mM
Tris-HCl [pH 7.0], 50 mM NaCl, 2 mM EDTA, 4 M urea, and 0.1 mM DTT) to
remove SDS with urea. Proteins were subsequently transferred overnight (25
mA, 25°C) onto NitroPure 45 m membranes (Cole Parmer, Vernon Hills, IL)
by the use of transfer buffer (10 mM Tris-HCl [pH 7.0], 0.05 M NaCl, 2 mM
EDTA, 0.1 mM DTT) and the general methods of Towbin et al. (26). Blots were
washed for 30 min in binding buffer (10 mM Tris-HCl [pH 7.0], 1 mM EDTA,
0.02% bovine serum albumin, 0.02% Ficoll, 0.02% [wt/vol] polyvinylpyrrolidone,
and 0.05 M NaCl). A biotin-labeled DNA probe for SW blotting was synthesized
in two steps. First, C. burnetii chromosomal DNA was randomly amplified using
a GenomiPhi V2 DNA amplification kit as instructed by the manufacturer (GE
Healthcare, Piscataway, NJ). Second, a portion of the amplicons was biotin
labeled with a NEBlot Phototope kit, as instructed by the manufacturer (New
England Biolabs, Ipswich, MA). DNA-binding proteins were identified by incubating blots in 20 ml of binding buffer plus the biotin-labeled DNA probe (60 min
at 25°C with rocking). The blots were washed four times with binding buffer by
replacing the entire volume at 15-min intervals. The resulting blots were UV
cross-linked using a GS gene linker (Bio-Rad) per the manufacturer’s instructions. Blots were developed using a chemiluminescent nucleic acid detection
module (Thermo Scientific, Rockford, IL) following the manufacturer’s instructions but with slight modifications, including the use of 60 ml of blocking
buffer (instead of 20 ml), a 1:3,000 dilution of streptavidin-horseradish peroxidase (instead of 1:300), and 60 ml of wash buffer (instead of 20 ml).
DNA-binding proteins were visualized using an LAS-3000 imaging system
(Fujifilm, Stamford, CT).
Mass spectrometry (MS) and proteomics. Protein spots representing potential
DNA-binding proteins on SW blots were excised from three silver-stained 2D
SDS-PAGE gels run in parallel with the blots. 2D gel spots were subjected to
trypsin digestion and matrix-assisted laser desorption ionization–time of flight
(MALDI-TOF) peptide mass fingerprinting and MALDI-tandem TOF
(MALDI-TOF/TOF) peptide sequencing (Alphalyse, Palo Alto, CA).
EMSAs. Electrophoretic mobility shift assays (EMSAs) were done using a
Lightshift chemiluminescence EMSA kit (Pierce, Rockford, IL) as instructed by
the manufacturer. The biotinylated-EBNA DNA probe (B-DNA) supplied in the
kit was used for all reactions. The EBNA extract (EE) provided in the kit was
used as a positive control DNA-binding protein. Heat-denatured EE (hd-EE)
was prepared by boiling for 10 min and cooling to 25°C. EMSA reactions were
prepared using 10⫻ binding buffer (2 l), 50% glycerol (1 l), 0.5 g/l X174
replicative form (RF) HaeIII DNA fragments (Invitrogen) (1 l), 1% NP-40 (1
l), and 40 fmol of biotin-EBNA. Native rBCP (1 to 10 M) or heat-denatured
rBCP (hd-rBCP) (1 to 10 M; boiled 10 min and cooled to 25°C) was added, and
the final volume was brought to 20 l with distilled water (dH2O). Following 20
min of incubation at 25°C, reaction mixtures were loaded onto a nondenaturing
polyacrylamide gel (5% [wt/vol] acrylamide) and electrophoretically separated at
25°C using 0.5% Tris-borate-EDTA buffer. Gels were then transferred at 4°C to
Immobilon-NY⫹ (Millipore, Bedford MA) using 0.5% Tris-borate-EDTA and a
Mini Trans-Blot cell (Bio-Rad) and then cross-linked with a Bio-Rad cross-linker
(program C3; damp membranes) at 150 mJ. Biotin-EBNA probes were visualized using a chemiluminescent nucleic acid detection module (Pierce) as instructed by the manufacturer and an LAS-3000 imaging system (Fujifilm).
Nucleic acid purification and manipulation and recombinant protein production. Chromosomal DNA was purified with a DNeasy blood and tissue kit as
instructed by the manufacturer (Qiagen). RNA was purified using a commercial
kit (RiboPure bacteria; Ambion, Austin, TX). Plasmid DNA was prepared with
a QIAprep spin miniprep kit (Qiagen). Nucleic acids were quantified by spectrophotometry at 260 nm. The C. burnetii bcp gene (CBU_0963) was amplified
using chromosomal DNA and primers containing SphI and PstI sites (BCP_For
and BCP_Rev) and PCR following standard protocols (2). The resulting amplicon was subjected to restriction endonuclease digestion with SphI and PstI and
cloned into the same sites of pQE30 (Qiagen) by a standard protocol (2) to
generate pQBCP, a plasmid encoding an in-frame N-terminal translational fusion of BCP and the vector’s His6 tag. Following transformation of E. coli M15
(pREP4) with pQBCP, induction and affinity purification of His6-tagged rBCP
(under native conditions) were accomplished using nickel-nitrilotriacetic acid
(Ni-NTA) agarose per the protocols of the manufacturer (Qiagen). A list of
plasmids and primers used in the study is provided in Table 1.
qRT-PCR. Quantitative real time-PCR (qRT-PCR) and RNA purification
were accomplished as previously described (21). Primer sets were designed using
Beacon Designer 7.5 software (Biosoft International, Palo Alto, CA), culminat-
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ing in primers specific to bcp (BCP2_For and BCP2_Rev; see Table 1). Amplified
cDNA was normalized to genome equivalents determined by quantitative PCR
(Q-PCR) and a primer set specific to Coxiella’s rpoS gene, as previously described
by Coleman et al. (8). Q-PCR data were also used to generate a growth curve for
Coxiella bacteria, showing genome equivalents as a function of time in infected
Vero cell cultures.
trans-complementation of E. coli bcp. Functional expression of Coxiella’s bcp
and trans-complementation of an E. coli bcp mutant were analyzed by comparing
growth phenotypes of E. coli strains LH100, LH200, and LH300 by using standard growth curves. Briefly, each strain was grown for 16 h in LB broth containing ampicillin (LBamp) (100 g/ml) at 37°C with shaking. A 2-ml aliquot was
subsequently used to inoculate 20 ml of LBamp. The resulting cultures were
grown for 2 h at 37°C to an optical density at 600 nm (OD600) of 1.0, and 500 l
was removed and used to inoculate 50 ml of LBamp containing 0 or 0.2 mM
tert-butyl hydroperoxide (t-BOOH). Bacterial growth was quantified spectrophotometrically at 600 nm over an 8-h period.
Prx and DNA protection assays. rBCP was assayed for Prx activity by the
methods of Jeong et al. (15). NADPH, thioredoxin (Trx), thioredoxin reductase
(TrxR), and t-BOOH were obtained from Sigma Chemical (St. Louis, MO).
Reaction volumes of 1 ml were used for reactions performed using various
amounts of purified C. burnetii rBCP (1 to 3 M rBCP in HEPES buffer [pH
7.0]). Typical reactions were done in 50 mM HEPES-NaOH (pH 7.0) containing
8 M Trx, 0.3 M TrxR, and 0.25 mM NADPH. Each reaction mixture was
mixed and incubated at 25°C for 2 min, prior to addition of t-BOOH to a final
concentration of 900 M. Absorbance was measured spectrophotometrically
(340 nm) at 30-s intervals during a 5-min reaction. Control assays were run
individually without rBCP, Trx, or TrxR or using 3 M hd-rBCP.
The ability of rBCP to protect supercoiled plasmid DNA against oxidative
damage was assayed essentially by the methods of Imlay et al. (14). Briefly,
supercoiled pUC19 (100 ng)–0.8% NaCl (wt/vol)–10 mM ethanol was mixed on
ice with rBCP at a final concentration of 0.1 M. H2O2 was added to achieve a
final concentration of 6 mM, and the resulting 20-l mixture was incubated for
30 min at 37°C. Reactions were immediately analyzed by electrophoresis through
ethidium bromide-stained 1.5% (wt/vol) agarose gels. Control reaction experiments using hd-rBCP (prepared as described above), or in the absence of rBCP
or H2O2, were also conducted. Densitometry analysis (performed by measuring
the intensity of pixels per square millimeter, corrected for background) of the
resulting DNA bands was done using Quantity One 4.6.2 software (Bio-Rad).
Statistical analysis. At least three independent determinations were used to
calculate means and standard deviations for all numerical data. Statistics and
graphs were analyzed and produced using InStat3 (GraphPad, La Jolla, CA)
and/or Excel 2003 (Microsoft, Redmond, WA) software. Statistical significance
was determined using Student’s t test; a P value of ⬍ 0.05 was considered
significant.

RESULTS AND DISCUSSION
Oxidative stress resistance is essential to the viability of
aerobic organisms and helps prevent membrane and macromolecular damage from endogenous ROS byproducts of metabolism, such as superoxide anions, H2O2, and hydroxyl radicals. In addition, an ability to resist host-derived, exogenous
ROS is a property shared by many bacterial pathogens (25),
especially those that reside within professional phagocytes,
such as C. burnetii. Bacteria deal with ROS by employing SOD,
catalase, and peroxidase or by nonenzymatic means involving
glutathione, vitamins A, C, and E, and carotenoids. Prx’s are
members of a biologically ubiquitous family of thiol-dependent
peroxidases that can be divided into two main groups that
contain either a single, N-terminal cysteine (i.e., 1-Cys Prx’s
with a peroxidatic Cys) or an N-terminal peroxidatic Cys plus
a second Cys residue (2-Cys Prx’s with a resolving Cys) for
reduction of H2O2 and organic hydroperoxides (29). Unlike
many peroxidases, Prx’s do not require redox cofactors (metals
or prosthetic groups) for activity, and reducing equivalents are
typically provided by NADPH through the Trx-TrxR pathway.
Bacterioferritin comigratory proteins (BCPs) were originally
named for their propensity to comigrate with bacterioferritin
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FIG. 1. Representative 2D SW blot prepared from a total cell lysate of purified Coxiella SCVs (70 g of total protein). IEF (pI, 3 to 10)
was employed in the first dimension and a 12.5% (wt/vol) acrylamide
SDS-PAGE gel was used in the second dimension, prior to blotting to
nitrocellulose. The SW blot was probed with biotin-labeled, C. burnetii
genomic DNA and visualized by streptavidin-horseradish peroxidase
(see text for details). Potential DNA-binding proteins from the SW
blot were identified by MALDI-TOF peptide mass fingerprinting and
MALDI-TOF/TOF peptide sequencing and are listed on the right. The
spot marked “X” could not be fingerprinted, despite numerous attempts.

proteins when subjected to SDS-PAGE, prior to elucidation of
their function (19). BCPs are atypical 2-Cys Prx’s whose redox
partner has been identified as Trx (15, 29). BCPs constitute a
subfamily of the thiol-specific-antioxidant (TSA)-alkyl hydroperoxidase C (AhpC) Prx family (15, 27) and are also referred to as PrxQ-like (13, 16) or Class 1 Prx’s (9). BCPs are
common to several bacterial pathogens (15); however, there is
little information regarding their role in conferring ROS resistance during pathogenesis. Previous work has shown that Helicobacter pylori BCP helps the pathogen establish long-term
colonization of the stomach in a murine model of infection
(28).
Discovery of BCP during SW blotting. In an effort to discover DNA-binding proteins that are possibly involved in C.
burnetii’s developmental cycle, SCVs were prepared and proteomes from a SCV lysate were resolved by 2D SDS-PAGE,
followed by SW blotting. SW blots of 2D SCV protein profiles
probed with random, biotinylated genomic Coxiella DNA fragments revealed four putative DNA-binding proteins, plus several minor species (Fig. 1). Analysis of the protein spots obtained from three individual 2D-SDS-PAGE gels was done by
MS (MALDI-TOF peptide mass fingerprinting and MALDITOF/TOF peptide sequencing of tryptic digests). The results
of the MS consistently identified BCP (CBU_0963), Com1
(CBU_1910), and a hypothetical protein (CBU_0603). MS
analysis of BCP generated four peptides with high-confidence
identification that represented ⬃25% coverage of BCP’s
amino acid sequence. A prominent, low-molecular-mass spot
of ⬃10 kDa and basic pI (marked “X” in Fig. 1) could not be
identified by MS, despite numerous attempts.
To verify the novel DNA-binding activity of BCP, Coxiella’s
bcp gene was cloned into pQE30 to create pQBCP, a plasmid
containing an in-frame translational fusion of BCP to an Nterminal His6 tag. pQBCP was also used to synthesize rBCP for
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FIG. 2. One-dimensional SW blot demonstrating DNA binding by
rBCP. Blots were prepared from 1D SDS-PAGE gels (12.5% [wt/vol]
acrylamide) with 5 g of protein per well. (A) SW blot probed with
biotin-labeled, C. burnetii genomic DNA. (B) SW blot duplicating that
shown in panel A but done without a biotin-labeled DNA probe.
Lanes: 1, biotinylated SDS-PAGE standards (Bio-Rad); 2, rBCP; 3,
rCom1; 4, rHbpA; 5, Kaleidoscope prestained standards (Bio-Rad).
The carbonic anyhdrase standard in lanes 5 (⬃40.3 kDa) demonstrates
intrinsic peroxidase activity and generates a signal on the SW blot
regardless of whether or not a DNA probe is employed. Blot signals
were detected using enhanced chemiluminescence (ECL) reagents and
a 3-min exposure.

purification via nickel affinity chromatography. SW blots were
prepared using rBCP and probed with biotinylated Coxiella
genomic DNA as for Fig. 1. Control blots done without a DNA
probe were run in parallel. The resulting SW blots clearly show
that rBCP binds DNA (Fig. 2A, lane 2) and that the signal is
dependent on the DNA probe (Fig. 2A versus 2B, lanes 2). SW
blots consistently showed two molecular mass forms of rBCP
(i.e., ⬃19 kDa and 21.5 kDa). The unexpected observation that
Com1 may be a DNA-binding protein (Fig. 1) was reexamined
by using rCom1, prepared from E. coli strain LH600, on the
SW blot. The results show that rCom1 does not bind DNA or
give a signal under the conditions employed (Fig. 2A and 2B,
lanes 3). One explanation for the apparent Com1 discrepancy
between Fig. 1 and 2 is that the proteins represented in Fig. 1
were prepared for 2D SDS-PAGE using urea, while those in
Fig. 2 were subjected to heat denaturing in Laemmli sample
buffer for the 1D SDS-PAGE gel. Com1, a predicted oxidoreductase (thioredoxin), may have retained activity following urea denaturation (Fig. 1; Com1 signal), whereas it was lost
upon heat denaturation (Fig. 2; no Com1 signal). Interestingly,
carbonic anyhdrase in the molecular mass standard (Fig. 2,
lanes 5) was clearly unaffected by heat denaturation and gave
a peroxidase signal that was not dependent on the presence of
a DNA probe. To ensure that reactivity in SW blots did not
arise from the presence of the His6 tag, an irrelevant fusion
protein, rHbpA (recombinant Bartonella quintana heme-binding protein A), was purified from E. coli strain LH700 and
included on the SW blot. The results clearly show that rHbpA

J. BACTERIOL.

FIG. 3. EMSA demonstrating DNA binding by rBCP. Components
of a LightShift chemiluminescence EMSA kit were used as instructed
by the manufacturer (Pierce). A comparison of mobilities for the
biotin-EBNA DNA probe following acrylamide gel electrophoresis,
blotting to nylon, and visualization of the signal is shown (see text for
details). Lanes show the results of reactions performed with a biotinEBNA DNA probe. Lanes: 1, no DNA-binding protein (negative control); 2, EBNA extract (positive control containing known DNA-binding protein); 3, heat-denatured (hd) EBNA extract; 4, 2 M rBCP; 5,
10 M rBCP; 6, 2 M hd-rBCP; 7, 10 M hd-rBCP. Sizes (indicated
to the right in base pairs) were determined by the use of a GeneRuler
biotinylated DNA ladder (KPL, Gaithersburg, MD).

did not give a signal after being subjected to probing with the
genomic DNA probe (Fig. 2A, lane 4).
Since DNA binding has not been described for any 2-Cys Prx
to date, we wanted to verify the activity by a different method.
To that end, EMSAs were done using rBCP and a LightShift
chemiluminescence EMSA kit (Pierce). EMSAs clearly demonstrated that rBCP bound to DNA in a concentration-dependent fashion, as shown by the protein’s ability to retard
electrophoretic migration of the kit’s biotin-EBNA probe compared to the negative control (Fig. 3, lanes 4 and 5 versus lane
1). Retardation of the biotin-EBNA probe’s mobility was also
observed with a positive-control DNA-binding protein (EBNA
extract) (Fig. 3, lane 2). Interestingly, DNA-binding activity of
EBNA extract was resistant to heat (Fig. 3, lane 3) whereas
rBCP activity was sensitive to heat denaturation at either of the
concentrations tested (Fig. 3, lanes 6 to 7). Taken as a whole,
the results of the two SW blot analyses (Fig. 1 and 2) and the
EMSA (Fig. 3) clearly demonstrate that BCP bound DNA. To
our knowledge, this is the first report of DNA-binding activity
by a 2-Cys Prx.
Because C. burnetii resides in a lysosome-like PV that is
undoubtedly rich in ROS, we focused our efforts on characterizing the putative BCP Prx (CBU_0963), with the underlying
hypothesis that it may serve as an antioxidant effector for the
pathogen. in silico analysis of the bcp locus in the RSA493
genome (GenBank number AE016828) revealed several noteworthy characteristics (Fig. 4A). First, the last nucleotide of
the bcp stop codon also serves as the “A” in the ATG start
codon of an sdr gene located downstream (CBU_0962), encoding a putative short-chain dehydrogenase (Cluster of Orthologous Group COG4221; short-chain alcohol dehydrogenase).
Second, a GenBank search revealed that the bcp-sdr linkage is
unique to C. burnetii and conserved in all five sequenced genomes of the bacterium. Of note is that sdr is annotated as a
pseudogene in CbuG_Q212 due to a frameshift (CbuG_1043;
GenBank number NC_011527). Third, the CBU_0964 open
reading frame (ORF) that occurs upstream of bcp is in the
opposite orientation and is separated by only three nucleotides
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FIG. 4. (A) Linkage map showing C. burnetii bcp with proximal genes, derived from genomic sequence data for Nine Mile strain RSA 493 (22).
Note the overlap of sdr with the 3⬘ end of bcp and the inverted but closely linked CBU_0964 and CBU_0961 ORFs. (B) A possible mechanism
whereby BCP serves as an atypical 2-Cys Prx enzyme for hydroperoxides, based on the model of Kong et al. (16). A predicted role of Trx as an
electron donor that reduces BCP through a cysteine thiol-disulfide exchange (plus TrxR for reduction of the Trx disulfide bond) is shown.

from bcp. The CBU_0961 ORF that lies downstream of sdr is
in the opposite orientation and separated by only 10 nucleotides from sdr (Fig. 4A). These observations lead to several
questions regarding regulation of the polygenic locus and suggest that bcp and sdr are cotranscribed due to their overlapping
linkages. It is tempting to speculate that the predicted oxidoreductase encoded by the sdr gene immediately downstream
of bcp also serves as an antioxidant effector.
The results of a BLASTP search indicate that BCP is a Prx
(a thioredoxin-dependent thiol peroxidase). BCP enzymes are
widely utilized by pathogenic bacteria to detoxify hydroperoxides and/or organic peroxides. The predicted amino acid sequence of BCP possesses the conserved catalytic triad common
to the BCP subfamily of Prx’s (i.e., Thr42, Cys45, Arg121),
wherein deprotonation of the catalytic (peroxidatic) Cys45 thiol
would presumably be facilitated by H-bonding with the hydroxyl group of Thr42 and the positively charged Arg121
sidechain, as previously described (10, 29). The activity of the
Coxiella BCP is predicted to conform to the process represented by the diagram shown in Fig. 4B. This scheme is based
upon a model first proposed for a 2-Cys BCP ortholog of
Sedum lineare (16) that shares many features with the Coxiella
BCP, including two Cys residues (Cys45 and Cys50) in the
N-terminal region that are separated by four amino acids and
a dependency on Trx for activity (see Fig. 7).
Expression of bcp during infection of host cells. To better
understand the role of BCP in Coxiella growth and metabolism,
we quantified Coxiella genomic DNA and bcp mRNA transcript levels over the course of synchronous 7-day infections of
cultured Vero cells. The results showed that bcp was maximally
expressed in Vero cells at days 2 to 3, coinciding with the
pathogen’s early exponential-phase growth (Fig. 5A) and with
the period when the large-cell-variant (LCV) morphotype predominates (8). With these data in mind, BCP likely functions
as an antioxidant for endogenous peroxides generated during

FIG. 5. bcp gene expression is maximal during early log-phase
growth of C. burnetii in synchronized infections of cultured Vero cells.
(A) Coxiella growth curve showing numbers of genome equivalents as
a function of postinfection time, as determined by Q-PCR of the same
source cultures used in qRT-PCR. (B) Corresponding qRT-PCR results, showing bcp mRNA transcript values normalized to the Coxiella
genome equivalents. The qRT-PCR and Q-PCR values represent the
means ⫾ standard deviations of the results of 6 independent experiments. Asterisks denote a statistically significant increase in bcp
mRNA relative to the day 0 postinfection value (P ⬍ 0.05).
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FIG. 6. Growth assays demonstrating functional expression of
cloned Coxiella bcp and its ability to trans-complement E. coli bcp.
Growth curves for an E. coli bcp mutant (LH200; ●) and a transcomplemented daughter strain (LH100; f) are shown; the curve for
the wild-type strain (LH300) was omitted for clarity. The upper lines
(blue and green) depict growth in LBamp, while the lower lines (black
and orange) show growth in an oxidative-stress growth medium (LBamp
containing 0.2 mM t-BOOH). OD600 values represent the means of the
results of 3 independent experiments ⫾ standard deviations. Asterisks
indicate a statistically significant (P ⬍ 0.05) difference between OD600
values at the indicated time points.

active replication. The qRT-PCR results (Fig. 5B) of this experiment are in good agreement with a previous proteomic
analysis of C. burnetii developmental stage morphotypes, which
showed that BCP, while present in the SCV proteome, was
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considerably more abundant (⬎2-fold greater abundance) in
the LCV proteome (7).
trans-complementation of E. coli bcp by using cloned Coxiella
bcp. For functional expression of C. burnetii bcp and verification of BCP’s role as an antioxidant in vivo, standard growth
curves were determined in triplicate experiments using otherwise isogenic E. coli strains, including LH300 (wild-type E. coli
transformed with pQE30; not shown), LH200 (bcp mutant
transformed with pQE30), and LH100 (bpc mutant trans-complemented with pQBCP). Growth in LBamp showed OD600
values that were not significantly different between strains (P ⱖ
0.05), although OD600 values for LH200 were consistently
lower during exponential-phase growth (Fig. 6). In contrast,
growth of these strains in an oxidative-stress growth medium
(LBamp containing 0.2 mM t-BOOH) showed statistically significant differences. Specifically, the trans-complemented strain
(LH100) produced significantly higher OD600 values at 2 to 8 h
than the bcp mutant (LH200) (Fig. 6). In addition, LH100
showed significantly higher OD600 values than the wild type
(LH300) at 2 to 4 h but was not significantly different from the
wild type at 5 to 8 h (wild-type data not shown). The significantly greater growth of LH100 relative to the LH200 strain
from 2 to 8 h was undoubtedly due to LH100’s enhanced ability
to deal with the exogenous t-BOOH through rBCP, especially
considering the isogenic background of these strains.
BCP’s Prx activity and protection of DNA from oxidative
damage. The Prx activity of rBCP was assayed using various
concentrations (0 to 3 M) of enzyme and t-BOOH as a
substrate, per several previous reports on Prx’s. A representative experiment is shown in Fig. 7. Regardless of the enzyme
concentration (1 to 3 M), results consistently showed that
rBCP is a heat-sensitive Prx that requires Trx and TrxR for in
vitro activity. Trx is maintained in a reduced state by TrxR in an

FIG. 7. Assay demonstrating in vitro peroxidase activity of rBCP. Percentages of NADPH substrate remaining as a function of incubation time
are shown. Reactions were done as described in the text but with reaction mixtures containing 3 M rBCP (filled circle), 0 M rBCP (open
diamond), 3 M heat-denatured rBCP (⫻ with vertical line), 0 M Trx (filled square), or 0 M TrxR (filled triangle). The assay is a representative
from three independent experiments.
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damage to the DNA. When combined with other results of this
study, the data suggest that BCP protects DNA through its
DNA binding and Prx activity and, to a lesser extent, in an
unknown manner that does not involve binding or enzyme
activities. These results are in keeping with previous work
showing that 1-Cys and 2-Cys Prx’s can protect DNA from
oxidative damage (17, 24).
Continued research on BCP and the other antioxidant cohorts enlisted by C. burnetii (e.g., SodB, SodC, AhpC, AhpD,
2-Cys Prx, and KatE) will provide additional clues regarding
effectors required to parasitize professional phagocytes, establish the parasitophorous vacuole, and allow for replication in
the harsh confines of this unusual intracellular niche.
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FIG. 8. rBCP protects supercoiled plasmid DNA from nicking by
H2O2. (A) Supercoiled (SC) pUC19 DNA (100 ng) (lane 1) was treated
with 6 mM H2O2 for 30 min, resulting in nicked (N) pUC19 (lane 2).
Reactions were also done in the presence of 0.1 M rBCP in its native
(lane 3) or heat-denatured “hd” (lane 4) state. Control reactions (lanes 1
and 2) were used as comparators for densitometry. (B) Densitometric
analysis of the gel lanes in panel A, where black bars represent the nicked
form of pUC19 and white bars depict supercoiled DNA. The assay is a
representative from three independent experiments.

NADPH-dependent reaction in this assay (see Fig. 4B). The
NADPH oxidation rate also directly correlated with the concentration of rBCP employed in these assays (data not shown).
Given the DNA-binding capability of Coxiella BCP (Fig. 1 to
3), its ability to confer resistance to t-BOOH in vivo (Fig. 6),
and its Prx activity in vitro (Fig. 7), we wanted to determine
whether rBCP would protect supercoiled DNA from oxidative
nicking by hydroxyl radicals, as previously reported for BCPs of
Sulfolobus solfataricus (17). To this end, supercoiled pUC19
plasmid DNA was prepared and incubated with 0 or 6 mM
H2O2 for 30 min at 37°C, in the presence of 0 or 0.1 M rBCP.
The results of the assay showed that supercoiled DNA was the
predominant species in reactions lacking both H2O2 and rBCP
(Fig. 8, lane 1). When H2O2 was added, the amount of the
nicked form of the plasmid increased by ⬃42% relative to the
untreated control amount (Fig. 8, lane 2 versus lane 1) as a
result of oxidative damage. Addition of 0.1 M rBCP to the
reactions decreased the amount of nicked DNA by ⬃32%
compared to reactions lacking enzyme (lane 3 versus lane 2).
Interestingly, hd-rBCP was able to reduce oxidative damage by
⬃17.5% when included in reactions (Fig. 8, lane 4 versus lane
2). Since heat denaturation destroys rBCP’s DNA binding (Fig.
3) and Prx activity (Fig. 7), the residual oxidative protection
conferred by hd-rBCP to DNA (Fig. 8) may have been due to
the denatured protein’s physical shielding or exclusion of H2O2
from the nucleic acid. Alternatively, hd-rBCP may have chelated trace iron ions present in the reaction buffer, thereby
reducing the Fenton reaction and consequential oxidative
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